CVS Health Buy Hold or Sell Recommendation

CVS -- USA Stock  

USD 54.89  0.23  0.42%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding CVS Health Corporation is 'Strong Hold'. Macroaxis provides CVS Health buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CVS positions. The advice algorithm takes into account all of CVS Health available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CVS buy-and-hold prospective. Check also CVS Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell CVS HealthBuy CVS Health
Strong Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon CVS Health Corporation has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0 and treynor ratio of 0.0
Macroaxis buy, hold, or sell suggestion module provides unbiased buy, hold, or sell recommendation that can be used to complement current average analyst sentiment on CVS Health Corporation. Our buy, hold, or sell suggestion engine suggest current market data to analyse the corporation potential to grow from the prospective of investors risk tolerance and investing horizon. To make sure CVS Health is not overpriced, please confirm all CVS Health fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that CVS Health has Price to Earning of 20.50X, we suggest you validate CVS Health Corporation market performance and probability of bankruptcy to make sure the company can sustain itself next year given your prevailing risk tolerance and investing horizon.

CVS Health Trading Alerts and Improvement Suggestions

CVS Health has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
The company has 95.55B in debt with debt to equity (D/E) ratio of 159.2 . This implies that the company may be unable to create cash to meet all of its financial commitments. CVS Health has Current Ratio of 0.92 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
The entity reported last year revenue of 209.62B. Reported Net Loss for the year was (174M) with profit before taxes, overhead, and interest of 30.88B.
Over 84.0% of CVS Health shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: CVS Health exotic insider transaction detected

CVS Health current analysts recommendations

Target Median Price68.00
Target Mean Price68.96
Recommendation Mean2.10
Target High Price95.00
Number Of Analyst Opinions23
Target Low Price55.00

CVS Health Returns Distribution Density

Mean Return0.11Value At Risk1.93
Potential Upside2.06Standard Deviation1.41
 Return Density 
      Distribution 

CVS Health Greeks

α
Alpha over DOW
=0.00
β
Beta against DOW=0.00
σ
Overall volatility
=1.44
Ir
Information ratio =0.00

CVS Health Volatility Alert

CVS Health Corporation has relatively low volatility with skewness of 1.03 and kurtosis of 3.55. However, we advise all investors to independently investigate CVS Health Corporation to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare CVS Health to competition

CVS Health Fundamental Vs Peers

FundamentalsCVS HealthPeer Average
Return On Equity0.06% (0.31)%
Return On Asset0.0004% (0.14)%
Profit Margin(0.021818)% (1.27)%
Operating Margin6.50% (5.51)%
Current Valuation155.69B16.62B
Shares Outstanding1.3B571.82M
Shares Owned by Insiders0.24% 10.09%
Shares Owned by Institutions83.80% 39.21%
Number of Shares Shorted20.24M4.71M
Price to Earning20.50X28.72X
Price to Book1.15X9.51X
Price to Sales0.33X11.42X
Revenue209.62B9.43B
Gross Profit30.88B27.38B
EBITDA13.63B3.9B
Net Income(174M)570.98M
Cash and Equivalents8.32B2.7B
Cash per Share6.41X5.01X
Total Debt95.55B5.32B
Debt to Equity159.20% 48.70%
Current Ratio0.94X2.16X
Book Value Per Share13.20X1.93K
Cash Flow from Operations11.33B971.22M
Short Ratio1.60X4.00X
Earnings Per Share(0.16)X3.12X
Price to Earnings To Growth1.34X4.89X
Number of Employees295K18.84K
Beta1.17-0.15
Market Capitalization68.7B19.03B
Total Asset93.66B29.47B
Retained Earnings10.26B9.33B
Working Capital7.21B1.48B
Current Asset30.38B9.34B
   Payment of 12902 shares by David Denton of CVS Health subject to Rule 16b-3 [view details]
Search macroaxis.com